PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,469 | +45.2% | 33,700 | +100.5% | 0.00% | – |
| Q2 2023 | $240,662 | +2598.0% | 16,806 | +2014.0% | 0.00% | – |
| Q4 2022 | $8,920 | +27.4% | 795 | +26.6% | 0.00% | – |
| Q3 2022 | $7,000 | -73.1% | 628 | -52.7% | 0.00% | – |
| Q4 2021 | $26,000 | +8.3% | 1,329 | +90.1% | 0.00% | – |
| Q2 2021 | $24,000 | -77.8% | 699 | -75.7% | 0.00% | – |
| Q1 2021 | $108,000 | +22.7% | 2,877 | +8.3% | 0.00% | – |
| Q4 2020 | $88,000 | +76.0% | 2,657 | +93.4% | 0.00% | – |
| Q3 2020 | $50,000 | -63.5% | 1,374 | -67.1% | 0.00% | – |
| Q2 2020 | $137,000 | -17.5% | 4,177 | -34.9% | 0.00% | – |
| Q1 2020 | $166,000 | -62.2% | 6,415 | -54.5% | 0.00% | – |
| Q4 2019 | $439,000 | – | 14,099 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $40,675,000 | 10.18% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $114,625,000 | 8.82% |
| Abingworth LLP | 1,203,135 | $23,606,000 | 5.72% |
| RA Capital Management | 3,115,008 | $61,272,000 | 1.08% |
| Avidity Partners Management LP | 1,896,000 | $37,294,000 | 0.79% |
| StepStone Group LP | 422,085 | $8,302,000 | 0.47% |
| Summit Rock Advisors, LP | 34,100 | $671,000 | 0.40% |
| Parkman Healthcare Partners LLC | 77,481 | $1,524,000 | 0.34% |
| Rhenman & Partners Asset Management AB | 186,210 | $3,624,000 | 0.24% |
| Ikarian Capital, LLC | 74,560 | $1,467,000 | 0.22% |